How much semaglutide do you start with — and what does that mean for cost?

What NICE and the licensed titration schedule actually say about 0.25 mg

The Wegovy dose ladder runs 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg, each held for roughly four weeks before moving to the next level, subject to tolerability and prescriber judgement. The 0.25 mg starting pen exists specifically to settle the gut, not to drive weight loss. NICE's technology appraisal TA875, which assessed semaglutide for weight management, based its recommendation on evidence gathered at the 2.4 mg maintenance dose. The STEP 1 trial, published in the New England Journal of Medicine, reported around 15% average weight reduction at that maintenance level over 68 weeks, and our page on how much you can lose on semaglutide puts those figures into practical context for people starting out. The 0.25 mg starter dose does not deliver that. A prescriber decides when you are ready to increase, and that decision is not automatic.

Why does this matter for cost? Because each pen in the schedule represents a different product and a different private market price. Quotes that advertise a low monthly figure often reflect the starter dose, not the dose most people eventually reach. The two are not interchangeable. A question our prescribers hear most weeks is: "I was quoted £X elsewhere, why is the price higher once I've been on it a while?" The honest answer is that starter-dose pricing and maintenance-dose pricing are different things, and a service that bundles them without explaining this isn't being straightforward with you.

For a detailed breakdown of how UK Wegovy private prices are structured across the full schedule, our page on Wegovy pricing in the UK covers each dose tier and what legitimate services typically include.

What headline prices for semaglutide often leave out

UK private pricing for semaglutide varies between providers and changes over time. Since Eli Lilly's widely reported list-price adjustment in autumn 2025, the broader private GLP-1 market has shifted, and Novo Nordisk's pricing for Wegovy has been subject to movement too, including a Novo Nordisk price reduction that affected UK availability. Reported private prices for semaglutide currently range roughly £149–£375 per month depending on dose and provider, though this fluctuates.

The figure advertised on a homepage rarely reflects the total cost of treatment. Look carefully for what is and is not included. Consultation fees are sometimes added separately. Prescription fees appear as a line item at some pharmacies. Delivery charges (especially for temperature-controlled medicines) can add up. Dose-review support and aftercare access, which matter a great deal on a titrating medicine, may be behind a paywall or simply absent. None of these extras are trivial if you're on a six-month or longer programme.

Our overview of semaglutide costs in the UK explains how to read a quote properly and what to ask any provider before committing.

Where nume sits on price, and why we're direct about it

We are not the cheapest option on the market. That is a choice, not an oversight. One price at nume covers your consultation, the prescriber's review, your prescription, your medicine, and free next-working-day delivery by DPD. Aftercare access for seven days a week is included too, as is the clinical re-review before any repeat. There is no subscription, no auto-renewal, and no hidden charge that appears when you're already committed. Our clinical team, led by a GPhC-registered Independent Prescriber, reviews every consultation personally, you can read more about that approach on our clinical lead's profile page.

Current pricing is listed on our treatment page. We don't publish per-pen figures in body copy because prices on a titrating schedule are genuinely dose-dependent, and a number stripped of context misleads more than it informs.

Price is the wrong starting point for a prescription medicine

Semaglutide for weight loss is a Prescription-Only Medicine. That legal status exists because it carries real clinical considerations: if you are wondering how much semaglutide you should start with, that question requires individual prescriber assessment rather than a one-size answer, contraindications that require individual assessment, and side effects that occasionally need prompt clinical attention. The MHRA's Yellow Card scheme exists in part because genuine clinical monitoring matters across a population using a relatively new medicine.

The MHRA has also warned publicly about counterfeit weight-loss pens sold through social media and unverified websites. A seller offering semaglutide without a clinical assessment, or at a price far below the UK private market, is a red flag, not a bargain. Any legitimate UK pharmacy can be verified on the GPhC register (nume's registration number is 9012878). Getting the clinical process right from the first 0.25 mg pen is what makes the rest of the programme safe and effective, and understanding how much water you mix with semaglutide when reconstituting your dose is one of the practical steps our team walks every patient through. That is the metric worth optimising for, not the headline price. Ready to find out whether semaglutide is right for you? Start your free consultation with our clinical team today.